Literature DB >> 10485592

Immunological modulation of human cardiac mast cells.

G Marone1, G de Crescenzo, G Florio, F Granata, V Dente, A Genovese.   

Abstract

Human mast cells, by elaborating various cytokines, chemokines and proinflammatory mediators play a complex role in several allergic and inflammatory disorders. Mast cells have been identified in human heart tissue in close proximity to the sarcolemma, in perivascular and adventitial locations and in the shoulder region of coronary atheroma. Human heart mast cells (HHMC) can be isolated from patients undergoing heart transplantation and can be immunologically activated in vitro to induce the release of tryptase, chymase, cysteinyl leukotriene C4 and prostaglandin D2. Several cytokines (e.g., stem cell factor and TNF-alpha) reside in secretory granules of HHMC. Mast cell density is increased in the hearts of patients with ischemic and idiopathic dilated cardiomyopathy. Cardiac mast cells might contribute to the evolution of atherosclerosis, dilated cardiomyopathy, cardiac and systemic anaphylaxis through the release of cytokines and vasoactive and proinflammatory mediators.

Entities:  

Mesh:

Year:  1999        PMID: 10485592     DOI: 10.1023/a:1020776807187

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  85 in total

1.  Mast cells and susceptibility to experimental atherosclerosis.

Authors:  P CONSTANTINIDES
Journal:  Science       Date:  1953-05-08       Impact factor: 47.728

2.  Myocardial mast cells in systemic sclerosis: a report of three fatal cases.

Authors:  A S Lichtbroun; L M Sandhaus; R C Giorno; H Kim; J R Seibold
Journal:  Am J Med       Date:  1990-09       Impact factor: 4.965

3.  Human mast cells produce the CD4+ T lymphocyte chemoattractant factor, IL-16.

Authors:  V Rumsaeng; W W Cruikshank; B Foster; C Prussin; A S Kirshenbaum; T A Davis; H Kornfeld; D M Center; D D Metcalfe
Journal:  J Immunol       Date:  1997-09-15       Impact factor: 5.422

4.  Resident cardiac mast cells degranulate and release preformed TNF-alpha, initiating the cytokine cascade in experimental canine myocardial ischemia/reperfusion.

Authors:  N G Frangogiannis; M L Lindsey; L H Michael; K A Youker; R B Bressler; L H Mendoza; R N Spengler; C W Smith; M L Entman
Journal:  Circulation       Date:  1998-08-18       Impact factor: 29.690

5.  Inactivation of thrombin by a complex between rat mast-cell protease 1 and heparin proteoglycan.

Authors:  G Pejler; K Söderström; A Karlström
Journal:  Biochem J       Date:  1994-04-15       Impact factor: 3.857

6.  Human basophil/mast cell releasability. IX. Heterogeneity of the effects of opioids on mediator release.

Authors:  C Stellato; R Cirillo; A de Paulis; V Casolaro; V Patella; P Mastronardi; B Mazzarella; G Marone
Journal:  Anesthesiology       Date:  1992-11       Impact factor: 7.892

7.  Higher susceptibility of mast-cell-deficient W/WV mutant mice to brain thromboembolism and mortality caused by intravenous injection of India ink.

Authors:  Y Kitamura; T Taguchi; M Yokoyama; M Inoue; A Yamatodani; H Asano; T Koyama; A Kanamaru; K Hatanaka; B K Wershil
Journal:  Am J Pathol       Date:  1986-03       Impact factor: 4.307

8.  [Cardiac mast cells in myocardial diseases].

Authors:  Y Hiruta; K Adachi; T Okamoto; Y Fujiura; H Toshima
Journal:  Kokyu To Junkan       Date:  1991-11

9.  Inactivation of human high molecular weight kininogen by human mast cell tryptase.

Authors:  M Maier; J Spragg; L B Schwartz
Journal:  J Immunol       Date:  1983-05       Impact factor: 5.422

10.  Human heart mast cells: a definitive case of mast cell heterogeneity.

Authors:  V Patella; G de Crescenzo; A Ciccarelli; I Marinò; M Adt; G Marone
Journal:  Int Arch Allergy Immunol       Date:  1995-04       Impact factor: 2.749

View more
  5 in total

1.  The emerging prominence of the cardiac mast cell as a potent mediator of adverse myocardial remodeling.

Authors:  Joseph S Janicki; Gregory L Brower; Scott P Levick
Journal:  Methods Mol Biol       Date:  2015

Review 2.  Histamine receptors in heart failure.

Authors:  Scott P Levick
Journal:  Heart Fail Rev       Date:  2021-10-08       Impact factor: 4.654

3.  Deficiency of mast cells in coronary artery endarterectomy of male patients with type 2 diabetes.

Authors:  Aleš Pleskovič; Olga Vraspir-Porenta; Ruda Zorc-Pleskovič; Danijel Petrovič; Metka Zorc; Aleksandra Milutinović
Journal:  Cardiovasc Diabetol       Date:  2011-05-14       Impact factor: 9.951

4.  Bronchial, alveolar, and vascular-induced anaphylaxis and irritant-induced cardiovascular and pulmonary responses.

Authors:  D B Yeates; D J Mussatto; W M Hameister; A Daza; T Chandra; L B Wong
Journal:  Environ Health Perspect       Date:  2001-08       Impact factor: 9.031

Review 5.  Human heart as a shock organ in anaphylaxis.

Authors:  Gianni Marone; Arturo Genovese; Gilda Varricchi; Francescopaolo Granata
Journal:  Allergo J Int       Date:  2014-03-19
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.